HIGHLIGHTS
- who: August et al. from the Capital Medical University, China have published the article: Real-world effectiveness of Yindan Jiedu granules-based treatment on patients infected with the SARS-CoV-2 Omicron variants BA.2 combined with high-risk factors: A cohort study, in the Journal: (JOURNAL) of April/22,/2022
- what: To reduce bias in the analysis, a 1:1 or 1:3 PSM was used.
- how: After PSM the results showed that the nucleic acid shedding time of the YDJDG group (n = 53) was 2.47 days shorter than that of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.